Outset Medical OM
NASDAQ OM
$3.22 -0.09 (-2.71%)
As of: Sep 10, 2026 · 3:40 PM EDT

Outset Medical (OM) EBITDA Margin Growth (3y) (2022 - 2026)

Analysis

Outset Medical (OM) EBITDA Margin Growth (3y) (2022 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin Growth (3y) (Qtr)
1 Abbott Laboratories 180.05 Bn 174.44 Bn 7.27 Bn -201.00
2 Intuitive Surgical 127.97 Bn 122.75 Bn 1.96 Bn 722.00
3 Medtronic 117.27 Bn 108.45 Bn 6.34 Bn 162.00
4 Stryker 103.98 Bn 100.50 Bn 4.50 Bn 586.00
5 Boston Scientific 63.03 Bn 62.49 Bn 3.85 Bn 736.00
6 Edwards Lifesciences 49.83 Bn 45.58 Bn 1.35 Bn 887.00
7 Alcon 32.93 Bn 31.47 Bn 1.68 Bn -1,075.00
8 Dexcom 32.26 Bn 30.31 Bn 830.00 Mn 963.00
9 Steris 20.73 Bn 20.25 Bn 684.20 Mn 244.00
10 Outset Medical 59.95 Mn -203.24 Mn 13.28 Mn 7,109.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7,109.00
Mar 31, 2026 6,921.00
Dec 31, 2025 6,337.00
Sep 30, 2025 9,396.00
Jun 30, 2025 12,081.00
Mar 31, 2025 6,428.00
Dec 31, 2024 7,074.00
Sep 30, 2024 3,135.00
Jun 30, 2024 627.00
Mar 31, 2024 -154.00
Dec 31, 2023 6,087.00
Sep 30, 2023 14,640.00
Jun 30, 2023 9,150.00
Mar 31, 2023 15,115.00
Dec 31, 2022 13,768.00
Sep 30, 2022 55,384.00
Jun 30, 2022 69,797.00
Mar 31, 2022 85,580.00